img

Global and India Gene-based Therapy Medicinal Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Gene-based Therapy Medicinal Market Report & Forecast 2024-2034

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global Gene-based Therapy Medicinal revenue was US$ 9063.6 million in 2022 and is forecast to a readjusted size of US$ 46360 million by 2029 with a CAGR of 26.0% during the review period (2024-2034).
In India, the Gene-based Therapy Medicinal revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2024-2034.
The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.
This report focuses on global and India Gene-based Therapy Medicinal market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Gene-based Therapy Medicinal will continue to grow rapidly in the future.
Global Gene-based Therapy Medicinal Scope and Market Size
Gene-based Therapy Medicinal market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Gene-based Therapy Medicinal market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Gene-based Therapy Medicinal market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.



By Company


Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System

Segment by Application


Neurological Diseases
Cancer
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Gene-based Therapy Medicinal definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Gene-based Therapy Medicinal companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Gene-based Therapy Medicinal in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene-based Therapy Medicinal revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Gene-based Therapy Medicinal Product Introduction
1.2 Global Gene-based Therapy Medicinal Outlook 2018 VS 2022 VS 2029
1.2.1 Global Gene-based Therapy Medicinal Market Size for the Year 2018-2029
1.2.2 India Gene-based Therapy Medicinal Market Size for the Year 2018-2029
1.3 Gene-based Therapy Medicinal Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Gene-based Therapy Medicinal in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Gene-based Therapy Medicinal Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Gene-based Therapy Medicinal Market Dynamics
1.4.1 Gene-based Therapy Medicinal Industry Trends
1.4.2 Gene-based Therapy Medicinal Market Drivers
1.4.3 Gene-based Therapy Medicinal Market Challenges
1.4.4 Gene-based Therapy Medicinal Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Gene-based Therapy Medicinal by Type
2.1 Gene-based Therapy Medicinal Market Segment by Type
2.1.1 Viral Gene Delivery System
2.1.2 Non-viral Gene Delivery System
2.2 Global Gene-based Therapy Medicinal Market Size by Type (2018, 2022 & 2029)
2.3 Global Gene-based Therapy Medicinal Market Size by Type (2018-2029)
2.4 India Gene-based Therapy Medicinal Market Size by Type (2018, 2022 & 2029)
2.5 India Gene-based Therapy Medicinal Market Size by Type (2018-2029)
3 Gene-based Therapy Medicinal by Application
3.1 Gene-based Therapy Medicinal Market Segment by Application
3.1.1 Neurological Diseases
3.1.2 Cancer
3.1.3 Other
3.2 Global Gene-based Therapy Medicinal Market Size by Application (2018, 2022 & 2029)
3.3 Global Gene-based Therapy Medicinal Market Size by Application (2018-2029)
3.4 India Gene-based Therapy Medicinal Market Size by Application (2018, 2022 & 2029)
3.5 India Gene-based Therapy Medicinal Market Size by Application (2018-2029)
4 Global Gene-based Therapy Medicinal Competitor Landscape by Company
4.1 Global Gene-based Therapy Medicinal Market Size by Company
4.1.1 Global Key Companies of Gene-based Therapy Medicinal, Ranked by Revenue (2022)
4.1.2 Global Gene-based Therapy Medicinal Revenue by Player (2018-2024)
4.2 Global Gene-based Therapy Medicinal Concentration Ratio (CR)
4.2.1 Gene-based Therapy Medicinal Market Concentration Ratio (CR) (2018-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Gene-based Therapy Medicinal in 2022
4.2.3 Global Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Gene-based Therapy Medicinal Head office and Area Served
4.4 Global Key Players of Gene-based Therapy Medicinal, Product and Application
4.5 Global Key Players of Gene-based Therapy Medicinal, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Gene-based Therapy Medicinal Market Size by Company
4.7.1 Key Players of Gene-based Therapy Medicinal in India, Ranked by Revenue (2022)
4.7.2 India Gene-based Therapy Medicinal Revenue by Players (2021, 2022 & 2024)
5 Global Gene-based Therapy Medicinal Market Size by Region
5.1 Global Gene-based Therapy Medicinal Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Gene-based Therapy Medicinal Market Size by Region (2018-2029)
5.2.1 Global Gene-based Therapy Medicinal Market Size by Region: 2018-2024
5.2.2 Global Gene-based Therapy Medicinal Market Size by Region (2024-2029)
6 Americas
6.1 Americas Gene-based Therapy Medicinal Market Size YoY Growth 2018-2029
6.2 Americas Gene-based Therapy Medicinal Market Size by Type
6.2.1 Americas Gene-based Therapy Medicinal Market Size by Type (2018-2024)
6.2.2 Americas Gene-based Therapy Medicinal Market Size by Type (2024-2029)
6.2.3 Americas Gene-based Therapy Medicinal Market Share by Type (2018-2029)
6.3 Americas Gene-based Therapy Medicinal Market Size by Application
6.3.1 Americas Gene-based Therapy Medicinal Market Size by Application (2018-2024)
6.3.2 Americas Gene-based Therapy Medicinal Market Size by Application (2024-2029)
6.3.3 Americas Gene-based Therapy Medicinal Market Share by Application (2018-2029)
6.4 Americas Gene-based Therapy Medicinal Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Gene-based Therapy Medicinal Market Size YoY Growth 2018-2029
7.2 EMEA Gene-based Therapy Medicinal Market Size by Type
7.2.1 EMEA Gene-based Therapy Medicinal Market Size by Type (2018-2024)
7.2.2 EMEA Gene-based Therapy Medicinal Market Size by Type (2024-2029)
7.2.3 EMEA Gene-based Therapy Medicinal Market Share by Type (2018-2029)
7.3 EMEA Gene-based Therapy Medicinal Market Size by Application
7.3.1 EMEA Gene-based Therapy Medicinal Market Size by Application (2018-2024)
7.3.2 EMEA Gene-based Therapy Medicinal Market Size by Application (2024-2029)
7.3.3 EMEA Gene-based Therapy Medicinal Market Share by Application (2018-2029)
7.4 EMEA Gene-based Therapy Medicinal Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Gene-based Therapy Medicinal Market Size YoY Growth 2018-2029
8.2 China Gene-based Therapy Medicinal Market Size by Type
8.2.1 China Gene-based Therapy Medicinal Market Size by Type (2018-2024)
8.2.2 China Gene-based Therapy Medicinal Market Size by Type (2024-2029)
8.2.3 China Gene-based Therapy Medicinal Market Share by Type (2018-2029)
8.3 China Gene-based Therapy Medicinal Market Size by Application
8.3.1 China Gene-based Therapy Medicinal Market Size by Application (2018-2024)
8.3.2 China Gene-based Therapy Medicinal Market Size by Application (2024-2029)
8.3.3 China Gene-based Therapy Medicinal Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Gene-based Therapy Medicinal Market Size YoY Growth 2018-2029
9.2 APAC Gene-based Therapy Medicinal Market Size by Type
9.2.1 APAC Gene-based Therapy Medicinal Market Size by Type (2018-2024)
9.2.2 APAC Gene-based Therapy Medicinal Market Size by Type (2024-2029)
9.2.3 APAC Gene-based Therapy Medicinal Market Share by Type (2018-2029)
9.3 APAC Gene-based Therapy Medicinal Market Size by Application
9.3.1 APAC Gene-based Therapy Medicinal Market Size by Application (2018-2024)
9.3.2 APAC Gene-based Therapy Medicinal Market Size by Application (2024-2029)
9.3.3 APAC Gene-based Therapy Medicinal Market Share by Application (2018-2029)
9.4 APAC Gene-based Therapy Medicinal Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Biogen
10.1.1 Biogen Company Details
10.1.2 Biogen Business Overview
10.1.3 Biogen Gene-based Therapy Medicinal Introduction
10.1.4 Biogen Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.1.5 Biogen Recent Development
10.2 Novartis
10.2.1 Novartis Company Details
10.2.2 Novartis Business Overview
10.2.3 Novartis Gene-based Therapy Medicinal Introduction
10.2.4 Novartis Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.2.5 Novartis Recent Development
10.3 Gilead Sciences
10.3.1 Gilead Sciences Company Details
10.3.2 Gilead Sciences Business Overview
10.3.3 Gilead Sciences Gene-based Therapy Medicinal Introduction
10.3.4 Gilead Sciences Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.3.5 Gilead Sciences Recent Development
10.4 Sarepta Therapeutics
10.4.1 Sarepta Therapeutics Company Details
10.4.2 Sarepta Therapeutics Business Overview
10.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Introduction
10.4.4 Sarepta Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.4.5 Sarepta Therapeutics Recent Development
10.5 Alnylam Pharmaceuticals
10.5.1 Alnylam Pharmaceuticals Company Details
10.5.2 Alnylam Pharmaceuticals Business Overview
10.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Introduction
10.5.4 Alnylam Pharmaceuticals Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.5.5 Alnylam Pharmaceuticals Recent Development
10.6 Amgen
10.6.1 Amgen Company Details
10.6.2 Amgen Business Overview
10.6.3 Amgen Gene-based Therapy Medicinal Introduction
10.6.4 Amgen Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.6.5 Amgen Recent Development
10.7 Spark Therapeutics
10.7.1 Spark Therapeutics Company Details
10.7.2 Spark Therapeutics Business Overview
10.7.3 Spark Therapeutics Gene-based Therapy Medicinal Introduction
10.7.4 Spark Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.7.5 Spark Therapeutics Recent Development
10.8 Akcea Therapeutics
10.8.1 Akcea Therapeutics Company Details
10.8.2 Akcea Therapeutics Business Overview
10.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Introduction
10.8.4 Akcea Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.8.5 Akcea Therapeutics Recent Development
10.9 Sunway Biotech
10.9.1 Sunway Biotech Company Details
10.9.2 Sunway Biotech Business Overview
10.9.3 Sunway Biotech Gene-based Therapy Medicinal Introduction
10.9.4 Sunway Biotech Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.9.5 Sunway Biotech Recent Development
10.10 SIBIONO
10.10.1 SIBIONO Company Details
10.10.2 SIBIONO Business Overview
10.10.3 SIBIONO Gene-based Therapy Medicinal Introduction
10.10.4 SIBIONO Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.10.5 SIBIONO Recent Development
10.11 AnGes
10.11.1 AnGes Company Details
10.11.2 AnGes Business Overview
10.11.3 AnGes Gene-based Therapy Medicinal Introduction
10.11.4 AnGes Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.11.5 AnGes Recent Development
10.12 Orchard Therapeutics
10.12.1 Orchard Therapeutics Company Details
10.12.2 Orchard Therapeutics Business Overview
10.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Introduction
10.12.4 Orchard Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.12.5 Orchard Therapeutics Recent Development
10.13 Human Stem Cells Institute
10.13.1 Human Stem Cells Institute Company Details
10.13.2 Human Stem Cells Institute Business Overview
10.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Introduction
10.13.4 Human Stem Cells Institute Revenue in Gene-based Therapy Medicinal Business (2018-2024)
10.13.5 Human Stem Cells Institute Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Gene-based Therapy Medicinal Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
Table 2. Gene-based Therapy Medicinal Market Trends
Table 3. Gene-based Therapy Medicinal Market Drivers
Table 4. Gene-based Therapy Medicinal Market Challenges
Table 5. Gene-based Therapy Medicinal Market Restraints
Table 6. Global Gene-based Therapy Medicinal Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. India Gene-based Therapy Medicinal Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Gene-based Therapy Medicinal Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. India Gene-based Therapy Medicinal Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Companies of Gene-based Therapy Medicinal, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Gene-based Therapy Medicinal Revenue by Player, (US$ Million), 2018-2024
Table 12. Global Gene-based Therapy Medicinal Revenue Share by Player, 2018-2024
Table 13. Global Gene-based Therapy Medicinal Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gene-based Therapy Medicinal by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Therapy Medicinal as of 2022)
Table 15. Global Key Players of Gene-based Therapy Medicinal, Headquarters and Area Served
Table 16. Global Key Players of Gene-based Therapy Medicinal, Product and Application
Table 17. Global Key Players of Gene-based Therapy Medicinal, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Gene-based Therapy Medicinal in India, Ranked by Revenue (2022) & (US$ Million)
Table 20. India Gene-based Therapy Medicinal Revenue by Players, (US$ Million), 2021, 2022 & 2024
Table 21. India Gene-based Therapy Medicinal Revenue Share by Players, 2021, 2022 & 2024
Table 22. Global Gene-based Therapy Medicinal Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 23. Global Gene-based Therapy Medicinal Market Size by Region (2018-2024) & (US$ Million)
Table 24. Global Gene-based Therapy Medicinal Market Size Forecast by Region (2024-2029) & (US$ Million)
Table 25. Americas Gene-based Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 26. Americas Gene-based Therapy Medicinal Market Size by Type (2024-2029) & (US$ Million)
Table 27. Americas Gene-based Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 28. Americas Gene-based Therapy Medicinal Market Size by Application (2024-2029) & (US$ Million)
Table 29. Americas Gene-based Therapy Medicinal Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 30. Americas Gene-based Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 31. Americas Gene-based Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 32. EMEA Gene-based Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 33. EMEA Gene-based Therapy Medicinal Market Size by Type (2024-2029) & (US$ Million)
Table 34. EMEA Gene-based Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 35. EMEA Gene-based Therapy Medicinal Market Size by Application (2024-2029) & (US$ Million)
Table 36. EMEA Gene-based Therapy Medicinal Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. EMEA Gene-based Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 38. EMEA Gene-based Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 39. China Gene-based Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 40. China Gene-based Therapy Medicinal Market Size by Type (2024-2029) & (US$ Million)
Table 41. China Gene-based Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 42. China Gene-based Therapy Medicinal Market Size by Application (2024-2029) & (US$ Million)
Table 43. China Gene-based Therapy Medicinal Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. APAC Gene-based Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 45. APAC Gene-based Therapy Medicinal Market Size by Type (2024-2029) & (US$ Million)
Table 46. APAC Gene-based Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 47. APAC Gene-based Therapy Medicinal Market Size by Application (2024-2029) & (US$ Million)
Table 48. APAC Gene-based Therapy Medicinal Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. APAC Gene-based Therapy Medicinal Market Size by Region (2018-2024) & (US$ Million)
Table 50. APAC Gene-based Therapy Medicinal Market Size by Region (2024-2029) & (US$ Million)
Table 51. Biogen Company Details
Table 52. Biogen Business Overview
Table 53. Biogen Gene-based Therapy Medicinal Product
Table 54. Biogen Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 55. Biogen Recent Development
Table 56. Novartis Company Details
Table 57. Novartis Business Overview
Table 58. Novartis Gene-based Therapy Medicinal Product
Table 59. Novartis Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Gilead Sciences Company Details
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Gene-based Therapy Medicinal Product
Table 64. Gilead Sciences Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Sarepta Therapeutics Company Details
Table 67. Sarepta Therapeutics Business Overview
Table 68. Sarepta Therapeutics Gene-based Therapy Medicinal Product
Table 69. Sarepta Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 70. Sarepta Therapeutics Recent Development
Table 71. Alnylam Pharmaceuticals Company Details
Table 72. Alnylam Pharmaceuticals Business Overview
Table 73. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product
Table 74. Alnylam Pharmaceuticals Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 75. Alnylam Pharmaceuticals Recent Development
Table 76. Amgen Company Details
Table 77. Amgen Business Overview
Table 78. Amgen Gene-based Therapy Medicinal Product
Table 79. Amgen Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 80. Amgen Recent Development
Table 81. Spark Therapeutics Company Details
Table 82. Spark Therapeutics Business Overview
Table 83. Spark Therapeutics Gene-based Therapy Medicinal Product
Table 84. Spark Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 85. Spark Therapeutics Recent Development
Table 86. Akcea Therapeutics Company Details
Table 87. Akcea Therapeutics Business Overview
Table 88. Akcea Therapeutics Gene-based Therapy Medicinal Product
Table 89. Akcea Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 90. Akcea Therapeutics Recent Development
Table 91. Sunway Biotech Company Details
Table 92. Sunway Biotech Business Overview
Table 93. Sunway Biotech Gene-based Therapy Medicinal Product
Table 94. Sunway Biotech Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 95. Sunway Biotech Recent Development
Table 96. SIBIONO Company Details
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Gene-based Therapy Medicinal Product
Table 99. SIBIONO Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Details
Table 102. AnGes Business Overview
Table 103. AnGes Gene-based Therapy Medicinal Product
Table 104. AnGes Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Details
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Gene-based Therapy Medicinal Product
Table 109. Orchard Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Human Stem Cells Institute Company Details
Table 112. Human Stem Cells Institute Business Overview
Table 113. Human Stem Cells Institute Gene-based Therapy Medicinal Product
Table 114. Human Stem Cells Institute Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 115. Human Stem Cells Institute Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene-based Therapy Medicinal Product Picture
Figure 2. Global Gene-based Therapy Medicinal Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Gene-based Therapy Medicinal Market Size 2018-2029 (US$ Million)
Figure 4. India Gene-based Therapy Medicinal Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 5. India Gene-based Therapy Medicinal Market Size 2018-2029 (US$ Million)
Figure 6. India Gene-based Therapy Medicinal Market Share in Global 2018-2029
Figure 7. Gene-based Therapy Medicinal Report Years Considered
Figure 8. Product Picture of Viral Gene Delivery System
Figure 9. Product Picture of Non-viral Gene Delivery System
Figure 10. Global Gene-based Therapy Medicinal Market Share by Type in 2022 & 2029
Figure 11. Global Gene-based Therapy Medicinal Market Size by Type (2018-2029) & (US$ Million)
Figure 12. Global Gene-based Therapy Medicinal Market Share by Type (2018-2029)
Figure 13. India Gene-based Therapy Medicinal Market Share by Type in 2022 & 2029
Figure 14. India Gene-based Therapy Medicinal Market Size by Type (2018-2029) & (US$ Million)
Figure 15. India Gene-based Therapy Medicinal Market Share by Type (2018-2029)
Figure 16. Product Picture of Neurological Diseases
Figure 17. Product Picture of Cancer
Figure 18. Product Picture of Other
Figure 19. Global Gene-based Therapy Medicinal Market Share by Application in 2022 & 2029
Figure 20. Global Gene-based Therapy Medicinal Market Size by Application (2018-2029) & (US$ Million)
Figure 21. Global Gene-based Therapy Medicinal Market Share by Application (2018-2029)
Figure 22. India Gene-based Therapy Medicinal Market Share by Application in 2022 & 2029
Figure 23. India Gene-based Therapy Medicinal Market Size by Application (2018-2029) & (US$ Million)
Figure 24. India Gene-based Therapy Medicinal Market Share by Application (2018-2029)
Figure 25. The Top 5 and 10 Largest Companies of Gene-based Therapy Medicinal in the World: Market Share by Gene-based Therapy Medicinal Revenue in 2022
Figure 26. Global Gene-based Therapy Medicinal Market Size Market Share by Region: 2018 VS 2022 VS 2029
Figure 27. Global Gene-based Therapy Medicinal Market Share by Region (2018-2029)
Figure 28. Americas Gene-based Therapy Medicinal Market Size Growth Rate 2018-2029 (US$ Million)
Figure 29. Americas Gene-based Therapy Medicinal Market Share by Type (2018-2029)
Figure 30. Americas Gene-based Therapy Medicinal Market Share by Application (2018-2029)
Figure 31. United States Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 32. Canada Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 33. Mexico Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 34. Brazil Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 35. EMEA Gene-based Therapy Medicinal Market Size Growth Rate 2018-2029 (US$ Million)
Figure 36. EMEA Gene-based Therapy Medicinal Market Share by Type (2018-2029)
Figure 37. EMEA Gene-based Therapy Medicinal Market Share by Application (2018-2029)
Figure 38. Europe Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 39. Middle East Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 40. Africa Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Gene-based Therapy Medicinal Market Size Growth Rate 2018-2029 (US$ Million)
Figure 42. China Gene-based Therapy Medicinal Market Share by Type (2018-2029)
Figure 43. China Gene-based Therapy Medicinal Market Share by Application (2018-2029)
Figure 44. APAC Gene-based Therapy Medicinal Market Size Growth Rate 2018-2029 (US$ Million)
Figure 45. APAC Gene-based Therapy Medicinal Market Share by Type (2018-2029)
Figure 46. APAC Gene-based Therapy Medicinal Market Share by Application (2018-2029)
Figure 47. Japan Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 48. South Korea Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 49. China Taiwan Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 50. Southeast Asia Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 51. India Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 52. Biogen Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 53. Novartis Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 54. Gilead Sciences Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 55. Sarepta Therapeutics Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 56. Alnylam Pharmaceuticals Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 57. Amgen Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 58. Spark Therapeutics Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 59. Akcea Therapeutics Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 60. Sunway Biotech Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 61. SIBIONO Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 62. AnGes Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 63. Orchard Therapeutics Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 64. Human Stem Cells Institute Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries